全文获取类型
收费全文 | 3648篇 |
免费 | 191篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 184篇 |
妇产科学 | 62篇 |
基础医学 | 466篇 |
口腔科学 | 63篇 |
临床医学 | 224篇 |
内科学 | 638篇 |
皮肤病学 | 88篇 |
神经病学 | 236篇 |
特种医学 | 143篇 |
外科学 | 404篇 |
综合类 | 242篇 |
一般理论 | 1篇 |
预防医学 | 252篇 |
眼科学 | 43篇 |
药学 | 298篇 |
1篇 | |
中国医学 | 13篇 |
肿瘤学 | 467篇 |
出版年
2023年 | 16篇 |
2022年 | 17篇 |
2021年 | 81篇 |
2020年 | 59篇 |
2019年 | 54篇 |
2018年 | 80篇 |
2017年 | 58篇 |
2016年 | 83篇 |
2015年 | 86篇 |
2014年 | 114篇 |
2013年 | 163篇 |
2012年 | 225篇 |
2011年 | 238篇 |
2010年 | 178篇 |
2009年 | 114篇 |
2008年 | 199篇 |
2007年 | 188篇 |
2006年 | 184篇 |
2005年 | 149篇 |
2004年 | 142篇 |
2003年 | 140篇 |
2002年 | 136篇 |
2001年 | 116篇 |
2000年 | 94篇 |
1999年 | 84篇 |
1998年 | 37篇 |
1997年 | 41篇 |
1996年 | 26篇 |
1995年 | 34篇 |
1994年 | 31篇 |
1993年 | 37篇 |
1992年 | 46篇 |
1991年 | 51篇 |
1990年 | 41篇 |
1989年 | 38篇 |
1988年 | 35篇 |
1987年 | 29篇 |
1986年 | 25篇 |
1985年 | 24篇 |
1984年 | 21篇 |
1983年 | 26篇 |
1979年 | 27篇 |
1978年 | 15篇 |
1977年 | 18篇 |
1976年 | 21篇 |
1975年 | 15篇 |
1974年 | 17篇 |
1973年 | 16篇 |
1972年 | 15篇 |
1971年 | 16篇 |
排序方式: 共有3843条查询结果,搜索用时 46 毫秒
1.
2.
3.
4.
5.
Pamela R. Hirschberg Pallabi Sarkar Suraj B. Teegala Vanessa H. Routh 《Journal of neuroendocrinology》2020,32(1)
The ventromedial hypothalamus (VMH) plays a complex role in glucose and energy homeostasis. The VMH is necessary for the counter‐regulatory response to hypoglycaemia (CRR) that increases hepatic gluconeogenesis to restore euglycaemia. On the other hand, the VMH also restrains hepatic glucose production during euglycaemia and stimulates peripheral glucose uptake. The VMH is also important for the ability of oestrogen to increase energy expenditure. This latter function is mediated by VMH modulation of the lateral/perifornical hypothalamic area (lateral/perifornical hypothalamus) orexin neurones. Activation of VMH AMP‐activated protein kinase (AMPK) is necessary for the CRR. By contrast, VMH AMPK inhibition favours decreased basal glucose levels and is required for oestrogen to increase energy expenditure. Specialised VMH glucose‐sensing neurones confer the ability to sense and respond to changes in blood glucose levels. Glucose‐excited (GE) neurones increase and glucose‐inhibited (GI) neurones decrease their activity as glucose levels rise. VMH GI neurones, in particular, appear to be important in the CRR, although a role for GE neurones cannot be discounted. AMPK mediates glucose sensing in VMH GI neurones suggesting that, although activation of these neurones is important for the CRR, it is necessary to silence them to lower basal glucose levels and enable oestrogen to increase energy expenditure. In support of this, we found that oestrogen reduces activation of VMH GI neurones in low glucose by inhibiting AMPK. In this review, we present the evidence underlying the role of the VMH in glucose and energy homeostasis. We then discuss the role of VMH glucose‐sensing neurones in mediating these effects, with a strong emphasis on oestrogenic regulation of glucose sensing and how this may affect glucose and energy homeostasis. 相似文献
6.
Mohamed M Soliman Debkumar Sarkar Ilya Glezerman Majid Maybody 《World Journal of Nephrology》2020,9(2):33-42
BACKGROUNDContrast-induced nephropathy (CIN) is a reversible form of acute kidney injury that occurs within 48-72 h of exposure to intravascular contrast material. CIN is the third leading cause of hospital-acquired acute kidney injury and accounts for 12% of such cases. Risk factors for CIN development can be divided into patient- and procedure-related. The former includes pre-existing chronic renal insufficiency and diabetes mellitus. The latter includes high contrast volume and repeated exposure over 72 h. The incidence of CIN is relatively low (up to 5%) in patients with intact renal function. However, in patients with known chronic renal insufficiency, the incidence can reach up to 27%.AIMTo examine the association between renal enhancement pattern on non-contrast enhanced computed tomographic (CT) images obtained immediately following hepatic artery embolization with development of CIN.METHODSRetrospective review of all patients who underwent hepatic artery embolization between 01/2010 and 01/2011 (n = 162) was performed. Patients without intraprocedural CT imaging (n = 51), combined embolization/ablation (n = 6) and those with chronic kidney disease (n = 21) were excluded. The study group comprised of 84 patients with 106 procedures. CIN was defined as 25% increase above baseline serum creatinine or absolute increase ≥ 0.5 mg/dL within 72 h post-embolization. Post-embolization CT was reviewed for renal enhancement patterns and presence of renal artery calcifications. The association between non-contrast CT findings and CIN development was examined by Fisher’s Exact Test.RESULTSCIN occurred in 11/106 (10.3%) procedures (Group A, n = 10). The renal enhancement pattern in patients who did not experience CIN (Group B, n = 74 with 95/106 procedures) was late excretory in 93/95 (98%) and early excretory (EE) in 2/95 (2%). However, in Group A, there was a significantly higher rate of EE pattern (6/11, 55%) compared to late excretory pattern (5/11) (P < 0.001). A significantly higher percentage of patients that developed CIN had renal artery calcifications (6/11 vs 20/95, 55% vs 21%, P = 0.02).CONCLUSIONA hyperdense renal parenchyma relative to surrounding skeletal muscle (EE pattern) and presence of renal artery calcifications on immediate post-HAE non-contrast CT images in patients with low risk for CIN are independently associated with CIN development. 相似文献
7.
8.
9.
Ethnic and regional variations have been found in the pharmacological treatment response. Though many efficacy studies have been conducted in India for antipsychotic treatment modalities of schizophrenia, there is a lack meta-analytic data of the existing literature from India. This study aimed to conduct a systematic review and meta-analysis of the antipsychotic treatment trials of schizophrenia in the Indian context. All controlled trials from India evaluating the clinical efficacy of antipsychotics in patients with schizophrenia were evaluated and 28 trials were included in the metanalysis. Effect sizes were computed using Cohen''s ‘d’ and risk of bias was evaluated. Meta analysis revealed superiority of first generation antipsychotics over placebo (mean effect size of 1.387, confidence interval of 1.127 to 1.648). Second generation antipsychotics were marginally better than first generation antipsychotics (effect size 0.106, confidence intervals 0.009 to 0.204). There was improvement in the methodology of the trials over time (Kendall tau=0.289, P=0.049), though no statistically significant increase in trial duration and sample size was noted. There is lack of data on long term efficacy of antipsychotic in schizophrenia from India. First generation antipsychotics have demonstrated benefits over placebo in patients with schizophrenia in the Indian context, though marginally lesser than second generation ones. 相似文献
10.
Youn-Kyung Kim Michael V. Zuccaro Changqing Zhang Dipak Sarkar Loredana Quadro 《肝胆外科与营养》2015,4(4):268-277